Botanix Pharmaceuticals Limited
BXPHF
$0.099
-$0.001-1.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.11% | 1,280.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.11% | 1,280.00% | |||
| Cost of Revenue | 2.11% | 104.14% | |||
| Gross Profit | 2.12% | 429.95% | |||
| SG&A Expenses | 2.12% | 68.81% | |||
| Depreciation & Amortization | 2.11% | -1.35% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.12% | 67.71% | |||
| Operating Income | -2.12% | -53.39% | |||
| Income Before Tax | -2.12% | -73.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.12% | -73.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.12% | -73.00% | |||
| EBIT | -2.12% | -53.39% | |||
| EBITDA | -2.12% | -55.37% | |||
| EPS Basic | -2.15% | -69.09% | |||
| Normalized Basic EPS | -1.72% | -65.71% | |||
| EPS Diluted | -2.15% | -69.09% | |||
| Normalized Diluted EPS | -1.72% | -65.71% | |||
| Average Basic Shares Outstanding | 0.00% | 3.08% | |||
| Average Diluted Shares Outstanding | 0.00% | 3.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||